Cargando…
Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease with unclear pathogenesis. IPF is considered as a risk factor for lung cancer. Compared to other lung cancers, small-cell lung cancer (SCLC) has a lower incidence, but has a more aggressive course. Patients with I...
Autores principales: | Zhang, Xiyue, Li, Wei, Li, Chunyan, Zhang, Jie, Su, Zhenzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051081/ https://www.ncbi.nlm.nih.gov/pubmed/33858421 http://dx.doi.org/10.1186/s12890-021-01489-4 |
Ejemplares similares
-
Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019) -
Clinical features of patients with small cell lung cancer and idiopathic pulmonary fibrosis treated with chemotherapy or chemoradiotherapy
por: Kanaji, Nobuhiro, et al.
Publicado: (2020) -
Lung function trajectories in patients with idiopathic pulmonary fibrosis
por: Neely, Megan L, et al.
Publicado: (2023) -
Lung Transplantation in Idiopathic Pulmonary Fibrosis
por: Laporta Hernandez, Rosalía, et al.
Publicado: (2018) -
Lung Transplantation for Idiopathic Pulmonary Fibrosis
por: Lamas, Daniela J., et al.
Publicado: (2013)